• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity.

作者信息

Han Junyan, Zhang Ning, Chen Danying, Gong Yuhuan, Li Guoli, Kong Yaxian, Pu Lin, Chen Chen, Liu Jingyuan, Wang Qi, Zhang Ju, Zhao Xuesen, Du Juan, Han Kai, Song Chuan, Wang Linghang, Hua Mingxi, Hao Yu, Song Rui, Song Yangzi, Yu Fengting, Yang Siyuan, Xiong Haofeng, Zhang Wei, Gao George F, Zhang Fujie, Li Ang, Zeng Hui, Bi Yuhai

机构信息

Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, 100101, China.

出版信息

Sci China Life Sci. 2022 Jan;65(1):223-226. doi: 10.1007/s11427-020-1947-y. Epub 2021 Jun 2.

DOI:10.1007/s11427-020-1947-y
PMID:34086155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8176871/
Abstract
摘要

相似文献

1
Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity.不同严重程度的新冠患者中IgM/IgG抗体反应的显著持久性。
Sci China Life Sci. 2022 Jan;65(1):223-226. doi: 10.1007/s11427-020-1947-y. Epub 2021 Jun 2.
2
Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.对 COVID-19 恢复期患者体内 SARS-CoV-2 抗体反应的特征描述。
J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10.
3
Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.评估 SARS-CoV-2 IgM 和 IgG II 抗体检测与 SARS-CoV-2 替代病毒中和试验之间的相关性。
J Med Virol. 2022 Jan;94(1):335-341. doi: 10.1002/jmv.27338. Epub 2021 Oct 5.
4
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.四种 SARS-CoV-2 抗体检测试剂在 COVID-19 患者及细菌性和非 SARS-CoV-2 病毒呼吸道感染患者中的诊断性能比较。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9.
5
SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.SARS-CoV-2 抗体反应不能预测 COVID-19 疾病严重程度。
Am J Clin Pathol. 2020 Sep 8;154(4):459-465. doi: 10.1093/ajcp/aqaa123.
6
Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.五种用于 SARS-CoV-2 抗体诊断的免疫分析方法在真实临床常规检测环境中的临床诊断性能评估。
Pan Afr Med J. 2021 May 3;39:3. doi: 10.11604/pamj.2021.39.3.26471. eCollection 2021.
7
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.COVID-19 患者症状出现后七个月内 SARS-CoV-2 特异性和中和抗体的动力学。
Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22.
8
Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.酶联免疫吸附试验评价 COVID-19 患者血清 IgM 和 IgG 抗体。
J Med Virol. 2021 May;93(5):2857-2866. doi: 10.1002/jmv.26741. Epub 2021 Mar 1.
9
Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients.伊朗 COVID-19 康复和死亡患者对 SARS-CoV-2 抗原的抗体反应差异。
Viral Immunol. 2021 Dec;34(10):708-713. doi: 10.1089/vim.2021.0061. Epub 2021 Sep 17.
10
Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.利用定性和定量免疫诊断检测监测重症 COVID-19 患者的特异性 IgM 和 IgG 产生：一项回顾性队列研究。
Front Immunol. 2021 Sep 3;12:705441. doi: 10.3389/fimmu.2021.705441. eCollection 2021.

引用本文的文献

1
Evaluation of oral health status and immunological parameters of hospitalized COVID-19 patients during acute and recovery phases: A randomized clinical trial.住院COVID-19患者急性期和恢复期口腔健康状况及免疫参数评估：一项随机临床试验。
J Dent Sci. 2024 Jul;19(3):1515-1524. doi: 10.1016/j.jds.2024.01.022. Epub 2024 Feb 5.
2
Relatively rapid evolution rates of SARS-CoV-2 spike gene at the primary stage of massive vaccination.在大规模疫苗接种初期，新冠病毒刺突基因相对较快的进化速率。
Biosaf Health. 2022 Aug;4(4):228-233. doi: 10.1016/j.bsheal.2022.07.001. Epub 2022 Jul 13.
3
An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19.关于从 COVID-19 中康复后免疫反应的保护效力的最新进展。
Front Immunol. 2022 May 20;13:884879. doi: 10.3389/fimmu.2022.884879. eCollection 2022.
4
Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic review.评估 COVID-19 疫苗随机对照试验的报告质量：系统评价。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2031453. doi: 10.1080/21645515.2022.2031453. Epub 2022 Feb 17.
5
Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China.中国武汉1年后针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）及其变体的抗体中和作用。
Innovation (Camb). 2022 Jan 25;3(1):100181. doi: 10.1016/j.xinn.2021.100181. Epub 2021 Nov 3.